Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Submitted by
admin
on February 9, 2017 - 10:49am
Source:
Marketwatch
News Tags:
Acorda Therapeutics
clinical trials
CVT-301
Parkinson's Disease
Headline:
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Do Not Allow Advertisers to Use My Personal information
